BK polyomavirus (BKPyV) is recognized as a pathogen that causes diseases such as hemorrhagic cystitis and nephritis after allogeneic hematopoietic stem cell transplantation (HSCT) or renal transplantation. BKPyV-associated disease is thought to occur through reactivation under immunosuppression. However, the possibility of its nosocomial transmission and the clinical significance of such transmission have not been elucidated. During a 6-month period, nine adult patients (median age: 47 years) who had hematological disorders and who were treated with HSCT (n = 7) or chemotherapy (n = 2) in a single hematology department developed hemorrhagic cystitis due to BKPyV infection. The polymerase chain reaction products of BKPyV DNA obtained from each patient were sequenced. Of the nine patients, six had subtype I, 2 had subtype IV, and 1 had subtype II or III. In the alignment of sequences, four and two of the six subtype I strains were completely homologous (100%). These results strongly suggest that BKPyV has the potential to cause nosocomial infection within a medical facility, especially among recipients of HSCT. Further studies are clearly warranted to elucidate the route(s) of BKPyV transmission in order to establish optimal infection control.
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Introduction
BK polyomavirus (BKPyV) is a member of the genus Polyomavirus, a pathogen that is well recognized to cause hemorrhagic cystitis and nephritis, mainly after kidney transplantation or hematopoietic stem cell transplantation (HSCT) (1) (2) (3) (4) . Primary infection with BKPyV is considered to occur in early childhood; a seropositivity rate of up to 90% in children 5-9 years of age has been reported.(5) On the basis of such high seropositivity, BKPyV-associated diseases are considered to occur as the reactivation of intrinsic BKPyV under certain conditions such as intensive immunosuppressive therapy. Because the transmission routes of BKPyV remain unclear and its resistance to inactivation is similar to that of other nonenveloped viruses, nosocomial infection from one patient shedding BKPyV to another via healthcare workers or medical facilities is possible. There has been only one report showing the possibility of nosocomial transmission of BKPyV. In that report, nosocomial transmission was proven in two of six pediatric HSCT recipients developing hemorrhagic cystitis by using epidemic curve plots, BKPyV genotyping, and contact tracing (6) . Since the number of evaluated subjects was small, it remains unclear whether transmission within medical facilities could definitely cause nosocomial BKPyV infection and result in clinically problematic hemorrhagic cystitis.
During a 6-month period, nine adult patients with hematological disorders, of whom eight were treated in the same hematology ward, developed BKPyV-associated hemorrhagic cystitis. This experience prompted us to explore the possibility of nosocomial BKPyV infection within the ward by conducting genomic sequence analysis of the virus isolated from each patient.
Materials and Methods

Patients and diagnosis of hemorrhagic cystitis due to BKPyV
During the period May through November 2013, nine adult patients with hematological disorders were diagnosed with symptomatic hemorrhagic cystitis due to BKPyV at the Department of Hematology of Keio University Hospital (Tokyo, Japan). At the onset of hemorrhagic cystitis, as a clinical practice, urine samples were obtained immediately and applied to qualitative polymerase chain reaction (PCR) analysis to detect BKPyV using methods described previously (7) . Diagnoses of hemorrhagic cystitis due to BKPyV were based on the presence of symptomatic cystitis with hematuria and the detection of BKPyV in the urine by qualitative PCR.
Hospital environments
The hematology ward had 41 beds comprising seven 4-bed rooms, three 2-bed rooms, and seven 1-bed rooms. Three of the 1-bed rooms with a laminar air flow were equipped with a private shower and toilet. Patients using the other rooms had shared showers and toilets. During the hospitalization, doctors and nurses took care of all these patients during hospitalization; all of those doctors and some of those nurses also cared for outpatients.
Viral load evaluation, subtype, and genomic sequence analysis of the isolated strains
The urine samples were cryopreserved and stored until they were used in further analysis. Previously reported methods of quantitative real-time PCR were used to evaluate the viral load in the urine (8) (9) (10) (11) . Briefly, sequences of real-time PCR primers and a probe for BKPyV were selected from the large T antigen region. The sequences of forward and reverse primers were For the subtype and genomic sequence analyses, viral DNAs were extracted from 0.2 mL of the stored urine by using a silica-based method (QIAamp MinElute Virus Spin kit, QIAGEN, Germantown, MD). Fragments of BKPyV DNA were amplified by PCR as previously described (12) . To obtain a 178-bp fragment within the BKPyV genome, primers PEP-1 (5 0 -AGTCTTTAGGGTCTTCTACC-3 0 ) and PEP-2 (5 0 -GGTGCCAACC-TATGGAACAG-3 0 ) were used. To avoid replication errors during the PCR to determine the gene sequences of BKPyV that were highly conserved among isolates, KOD DNA polymerase (Toyobo, Tokyo, Japan), whose PCR fidelity is known to be among the highest, was used (13) . In addition, completely identical sequences were confirmed in 30 clones obtained from the PCR product amplified using a monoclonal BKPyV gene as a template in a control experiment. After the separation and purification of PCR products by using the Wizard SV Gel and PCR Clean-Up System (Promega, Madison, WI), DNA sequences were determined by direct sequencing using PEP-1 and PEP-2 primers. DNA sequences were aligned, and a phylogenetic tree was drawn using ClustalW (14, 15) .
Phylogenetic analyses
Phylogenetic relationships among DNA sequences identified in this study (accession numbers written in boldface and reference sequences of BKPyV and related viruses obtained from GenBank) were analyzed using MEGA7 for the neighbor-joining and maximum-parsimony methods (16) . The evolutionary distances were computed using the maximum composite likelihood method.
Results
Patients
Patient characteristics are shown in Table 1 . The median age was 47 years. Eight patients had various hematological malignancies, and one had aplastic anemia. Seven recipients of HSCT received high-dose chemotherapy, with or without total body irradiation as conditioning, and immunosuppressive agents such as calcineurin inhibitors and/or prednisolone. The remaining two patients (Cases 8 and 9) received standard-dose chemotherapy such as CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy and bortezomib-based chemotherapy. One patient (Case 1) received anti-thymocyte globulin for graftversus-host disease prophylaxis. Viral loads, evaluated by real-time PCR, were 1 9 10 7 copies/mL or higher in five patients (Cases 2, 4, 5, 6, and 7; Table 1 ). In all patients, hemorrhagic cystitis improved with supportive measures such as hydration, forced diuresis, and bladder irrigation.
Subtype and homology evaluation
BKPyV DNAs isolated from urine samples were analyzed to identify the patients' BKPyV strains. Figure 1 shows the sequence alignments of the isolates obtained from the nine patients. The sequences of four lesions in the viral large T antigen region are shown in Table 2 . The BKPyV subtypes were I in six isolates, IV in two, and II or III in one. A phylogenetic tree was constructed based on these data together with the previously reported reference sequences (Figure 2 ). In the alignments of all the obtained sequences, the four subtype I strains obtained from Cases 2, 5, 6, and 7 and the remaining two subtype I strains from Cases 4 and 8 were 100% homologous ( Figure 1 ). The two subtype IV strains obtained from Cases 1 and 9 were 99% homologous.
Hospitalization period and onset of hemorrhagic cystitis All patients except Case 8 developed hemorrhagic cystitis during or after hospitalization at the same hematology ward. The relationship between each patient's hospitalization period and the onset of hemorrhagic cystitis is shown in Figure 3 . With regard to the hospitalization periods of Cases 2, 5, 6, and 7, Case 2 had the first onset of hemorrhagic cystitis, and the hospitalization periods of the other three cases overlapped with that of Case 2 ( Figure 1) . Similarly, the onset of hemorrhagic cystitis in Case 1 was followed by that of Case 9, also with overlapping hospitalization periods (Figure 1 ). However, Case 8 developed hemorrhagic cystitis in an outpatient setting without hospitalization in the same ward, indicating a 1  TCC  GAG  GAG  GAA  IV  2  TCT  GAA  GAA  GAA  I  3  TCC  GAA  GAA  GAG  II or III  4  TCT  GAA  GAA  GAA  I  5  TCT  GAA  GAA  GAA  I  6  TCT  GAA  GAA  GAA  I  7  TCT  GAA  GAA  GAA  I  8  TCT  GAA  GAA  GAA  I  9  TCC  GAG  GAG  GAA  IV LTA, large T antigen.
lack of direct contact with Case 4. This patient visited the outpatient service at least once or twice a month during this period.
Discussion
It was considered unusual that nine patients with hematological disorders developed hemorrhagic cystitis due to BKPyV in a 6-month period within the same hematology ward, including one exceptional case in the outpatient service. Therefore, we explored the possibility of nosocomial infection by sequencing a specific region of the BKPyV genome to assess the homology of each strain found in the present study. Among the nine strains, three clusters, excluding one strain, with high or complete homology were identified, suggesting the possibility of nosocomial infection in this period. To the best of our knowledge, only one report has shown the possibility of nosocomial transmission of BKPyV, in which nosocomial transmission between two pediatric HSCT recipients was proven (6) . The present report is the first to indicate nosocomial transmission in adult patients within a medical facility by demonstrating the genomic homology of isolated strains of BKPyV.
Little is known about the modes of BKPyV transmission, such as the source of viral exposure, the portal of entry, and the pathophysiological role of lifelong latency. It is considered that the possible route of transmission is oral or respiratory. Despite the lack of evidence to support specific infection-control measures, guidelines mention that the separation of patients with disseminated BKPyV infection from other patients should be considered (17, 18) . In the present study, nosocomial BKPyV infection resulting in an outbreak of hemorrhagic cystitis occurred primarily in an inpatient setting. The route of transmission could be from patient to patient or via healthcare workers, facilities, or toilet equipment (19) . Further studies are necessary to elucidate the routes of transmission by detecting BKPyV in the hospital environment, and would greatly help to control the spread of infection. It should be noted that an outpatient (Case 8) developed hemorrhagic cystitis from the same strain detected in an inpatient (Case 4). This patient (Case 8) had no direct contact with the other patients. Therefore, transmission likely occurred via healthcare workers or some other route.
BKPyV is ubiquitous in humans; more than 90% of individuals in normal populations experience its primary infection in early childhood. With such a high prevalence of BKPyV infection, significant numbers of recipients of allogeneic HSCT or kidney transplantation are at high risk for developing hemorrhagic cystitis, nephritis, and other diseases due to BKPyV reactivation (1-3). In the setting of allogeneic HSCT, hemorrhagic cystitis is the most common type of BKPyV-associated disease, whose incidence has been reported to be 12-24% (1, 6, 20, 21) . Hemorrhagic cystitis does impair quality of life and could prolong hospitalization. In addition, not only hemorrhagic cystitis but also BK viruria or viremia without clinical manifestation has been reported to be related to a poorer rate of survival and/or to progressive renal dysfunction (4, 20) . Therefore, the incidence of BKPyV-associated disease might have been underestimated, and thus the prevention and effective treatment of BKPyV infection or disease in allogeneic HSCT recipients could improve the transplant outcome. As our findings strongly suggest the possibility of nosocomial BKPyV infection, strict infection control measures for BKPyV should be implemented to prevent exogenous exposure if any patients develop hemorrhagic cystitis or BKPyV viruria in a hematology ward, especially an HSCT unit (19) .
There has been accumulating evidence that viral load in the urine would be one of the useful diagnostic assets for hemorrhagic cystitis due to BKPyV (20, 22) . On the basis of such evidence, high urine viral load has been recommended to be included in the diagnostic criteria (17, 18) . A urine BKPyV load of 10 7 copies/mL has been proposed as the high viral load. In this regard, four patients in our study did not fulfill the criteria. However, the remaining four patients in the largest cluster of BKPyV complete homology (Cases 2, 5, 6, and 7) did yield high viral loads. Therefore, the diagnosis of hemorrhagic cystitis due to BKPyV is considered definite at least in these four patients. In addition, plasma/serum viral load has recently been reported to be useful in the diagnosis and prediction of BKPyV infection (23, 24) . Since neither serum nor plasma samples were available, viremia could not been assessed in our study. If it had been, it would have provided more useful and important information.
Among our nine patients who developed BKPyV hemorrhagic cystitis, two had relapsed/refractory lymphoid malignancies (malignant lymphoma and plasma cell leukemia) and were treated with chemotherapy including steroids but not HSCT. Although the number of cases in our study was small, this finding indicated that such non-HSCT immunosuppressed hematological malignancies could also make patients susceptible to nosocomial BKPyV infection and diseases. Physicians should consider the possibility of nosocomial infection when they encounter non-HSCT patients who have developed hemorrhagic cystitis due to BKPyV.
The BKPyV has four distinguishable subtypes, labeled I to IV, whose distributions have been examined in several populations (7, (25) (26) (27) (28) . All of these reports consistently demonstrated that subtype I was predominant. In particular, Takasaka et al evaluated Japanese renal transplant and HSCT recipients, and found a greater than 80% predominance of subtype I followed by IV (13%) (7). Indeed, subtype I was the predominant one in our Japanese patients. However, the present results indicated the possibility of intra-institutional nosocomial BKPyV infection, which has the potential to affect the subtype distribution. Therefore, we should be cautious in interpreting the results of single-institution BKPyV subtype distribution analysis.
Our study has several limitations aside from the small sample size. The major limitation is that BKPyV serology was not available, since serum samples had not been stored for future analysis at any time point. Because of the lack of serology data, it is impossible to completely exclude the reactivation of BKPyV as the pathogenesis of hemorrhagic cystitis (6, 29) .
In conclusion, physicians should recognize that BKPyV could potentially spread nosocomially among patients with hematological disorders. Further studies to elucidate transmission routes are clearly warranted in order to establish optimal control over the spread of BKPyV infection. It is also important to investigate the possibility of nosocomial infection in other patient settings.
